Allergan, Inc. News Headlines

AGN 
$170.2
*  
1.64
0.97%
Get AGN Alerts
*Delayed - data as of Sep. 16, 2014  -  Find a broker to begin trading AGN now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    AGN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Why Salix Pharmaceuticals (SLXP) Stock Is Higher Today
9/17/2014 8:28:00 AM - TheStreet

Aegon Determines Stock Fraction Interim Dividend; To Buy Back Shares
9/17/2014 2:10:00 AM - RTT News

Roche Starts Trials on Lampalizumab for Geographic Atrophy - Analyst Blog
9/16/2014 6:10:00 PM - Zacks.com

AstraZeneca and Eli Lilly Collaborate for Alzheimer's Drug - Analyst Blog
9/16/2014 5:20:00 PM - Zacks.com

TSX Ends Higher Ahead Of Fed Meet Outcome -- Canadian Commentary
9/16/2014 5:17:00 PM - RTT News

Gilead (GILD) Slips on Generic Sovaldi Licensing Deals - Analyst Blog
9/16/2014 4:45:00 PM - Zacks.com

Avanir Pharmaceuticals Shoots Up on Positive AVP-923 Data - Analyst Blog
9/16/2014 3:50:00 PM - Zacks.com

Why It's Time for Allergan Shareholders to Take Some Profits
9/16/2014 1:09:00 PM - TheStreet

TSX Falls As Markets Await Federal Reserve Decision
9/16/2014 11:17:00 AM - RTT News

In the news: GM to pay for 19 deaths, Boeing teams up with Bezos and more
9/16/2014 9:16:00 AM - Market Intelligence Center

Bay Street Seen Quiet Ahead Of Tomorrow's Fed Decision -- Canadian Commentary
9/16/2014 9:00:00 AM - RTT News

Pershing Square, Valeant Pharma Settle Litigation With Allergan - Quick Facts
9/16/2014 1:56:00 AM - RTT News

NPS Pharmaceuticals' Natpara Gets Positive FDA Panel Vote - Analyst Blog
9/15/2014 7:05:00 PM - Zacks.com

Alnylam Expands Pipeline with Preeclampsia Drug ALN-AGT - Analyst Blog
9/15/2014 7:00:00 PM - Zacks.com

QLT Unveils Positive Retreatment Study Data - Analyst Blog
9/15/2014 6:50:00 PM - Zacks.com

Novartis Presents Positive Data on Lucentis and Jetrea - Analyst Blog
9/15/2014 5:35:00 PM - Zacks.com

Abbott Labs Presents Positive One-Year Data on Absorb - Analyst Blog
9/15/2014 5:20:00 PM - Zacks.com

Eli Lilly's Cyramza Scores in Colorectal Cancer Study - Analyst Blog
9/15/2014 4:30:00 PM - Zacks.com

Sanofi Reports Data on Multiple Sclerosis Drug Lemtrada - Analyst Blog
9/12/2014 5:30:00 PM - Zacks.com

Will Allergan's Board Be Revamped to Aid Valeant Buyout? - Analyst Blog
9/12/2014 5:25:00 PM - Zacks.com

Novo Nordisk's Saxenda Gets Positive Opinion for Obesity - Analyst Blog
9/12/2014 5:10:00 PM - Zacks.com

AbbVie's Humira Positive in Phase III Skin Disease Study - Analyst Blog
9/12/2014 5:05:00 PM - Zacks.com

Abbott Labs (ABT) to Repurchase Shares for $3B - Analyst Blog
9/12/2014 4:50:00 PM - Zacks.com

Correction to Allergan Story
9/12/2014 9:32:00 AM - Dow Jones Business News

U.S. Hot Stocks: Hot Stocks to Watch
9/12/2014 9:26:00 AM - Dow Jones Business News